
### [NCIT:C4032](http://purl.obolibrary.org/obo/NCIT_C4032)
**Label:** Bladder Adenocarcinoma

**Subclasses:** [NCIT:C4995](http://purl.obolibrary.org/obo/NCIT_C4995) (Recurrent Bladder Adenocarcinoma), [NCIT:C8898](http://purl.obolibrary.org/obo/NCIT_C8898) (Stage IV Bladder Adenocarcinoma), [NCIT:C8896](http://purl.obolibrary.org/obo/NCIT_C8896) (Stage II Bladder Adenocarcinoma), [NCIT:C8897](http://purl.obolibrary.org/obo/NCIT_C8897) (Stage III Bladder Adenocarcinoma), [NCIT:C8894](http://purl.obolibrary.org/obo/NCIT_C8894) (Stage 0 Bladder Adenocarcinoma), [NCIT:C8895](http://purl.obolibrary.org/obo/NCIT_C8895) (Stage I Bladder Adenocarcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.75%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40314](http://purl.obolibrary.org/obo/NCIT_C40314) (Vulvar Trichoepithelioma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40312](http://purl.obolibrary.org/obo/NCIT_C40312) (Vulvar Nodular Hidradenoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40311](http://purl.obolibrary.org/obo/NCIT_C40311) (Vulvar Syringoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40309](http://purl.obolibrary.org/obo/NCIT_C40309) (Vulvar Sebaceous Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40308](http://purl.obolibrary.org/obo/NCIT_C40308) (Vulvar Apocrine Adenocarcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40307](http://purl.obolibrary.org/obo/NCIT_C40307) (Vulvar Clear Cell Hidradenocarcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40306](http://purl.obolibrary.org/obo/NCIT_C40306) (Vulvar Eccrine Porocarcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40301](http://purl.obolibrary.org/obo/NCIT_C40301) (Adenoma of Minor Vestibular Glands))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40299](http://purl.obolibrary.org/obo/NCIT_C40299) (Bartholin Gland Adenoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40298](http://purl.obolibrary.org/obo/NCIT_C40298) (Bartholin Gland Small Cell Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40297](http://purl.obolibrary.org/obo/NCIT_C40297) (Bartholin Gland Transitional Cell Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40296](http://purl.obolibrary.org/obo/NCIT_C40296) (Bartholin Gland Adenosquamous Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40295](http://purl.obolibrary.org/obo/NCIT_C40295) (Bartholin Gland Adenoid Cystic Carcinoma))) 37.63%


